Description
Eterna Peptides presents premium-grade Klow Capsules (103.5mg), an advanced oral longevity and tissue regeneration research formulation. Combining four high-purity synthetic peptides with a structural cellular hydration matrix inside a single precise oral delivery format, Klow Capsules serve as an elite investigative tool for studying multi-pathway extracellular matrix repair, systemic inflammation mitigation, and accelerated tissue recovery cascades.
### Advanced 103.5mg Synergistic Mass Profile
Each carefully calibrated capsule contains a precise distribution of targeted research compounds:
* **GHK-Cu (2mg):** A high-purity copper-binding tripeptide widely investigated for its ability to upregulate collagen and elastin gene expression in fibroblasts while acting as an organic copper chaperone for vital antioxidant enzymes.
* **BPC-157 (5mg):** A stable synthetic pentadecapeptide researched for its capacity to accelerate soft tissue repair, promote tendon-to-bone healing kinetics, and support gastric mucosal cytoprotection.
* **TB-500 (6mg):** A low-molecular-weight fragment of Thymosin Beta-4 actively studied for its role in promoting actin polymerization, endothelial cell migration, and rapid localized microvascular branching (angiogenesis).
* **KPV (0.5mg / 500mcg):** A naturally modeled tripeptide tracking advanced cellular immunomodulation. KPV is studied for its potent ability to downregulate NF-kB signaling pathways, suppressing pro-inflammatory cytokine expression.
* **Hyaluronic Acid (90mg):** A major structural component of the extracellular matrix that provides a deeply hydrated, biocompatible fluid environment to support cellular migration, structural density, and tissue elasticity.
### Mechanism of Action
The Klow matrix operates via distinct, complementary biological pathways to explore mucosal and systemic recovery:
* **Fibroblast & Structural Recouping:** GHK-Cu and BPC-157 work concurrently to stimulate structural fibroblasts, optimizing tissue density and driving smooth cellular re-epithelialization.
* **Accelerated Cell Migration:** TB-500 coordinates with the fluid environment provided by Hyaluronic Acid to facilitate the smooth, high-velocity migration of repair substrates directly to damaged cellular zones.
* **Inflammatory Cascade Attenuation:** KPV and BPC-157 actively suppress chronic inflammatory signaling pathways, neutralizing cellular stress to shield fragile, recovering tissue boundaries.
### Research Applications
In preclinical and in vitro laboratory models, Klow Capsules 103.5mg are actively utilized to investigate:
* Advanced systemic tissue remodeling, myofibrillar preservation, and dermatological matrix density improvements.
* High-velocity soft tissue wound healing, tendon/ligament repair, and joint matrix stabilization.
* Systemic anti-inflammatory behaviors, cell longevity dynamics, and microvascular perfusion optimization.
* The comparative baseline bioavailability and structural stability of multi-peptide oral capsule delivery systems.
Our Klow Capsules are manufactured under strict laboratory quality control guidelines to ensure absolute ingredient standardization, precise compound weight validation, and dependable experimental reproducibility.
—
*Disclaimer: This product is sold strictly for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic purposes.*
